Este website é destinado para o público portugués. Para que você verifique se o website de seu país está disponpivel, selecione o seu país da lista.
Fechar
Fechar
Fechar
Fechar
Fechar
Fechar

O nosso portfolio diversificado reforça o nosso compromisso com a Saúde das Mulheres

Fechar

Novidades da Theramex

Fechar

Contacte-nos

Fechar

Carreiras

28 February 2022

Theramex Statement: Russia-Ukraine Crisis

We are deeply saddened by the current crisis occurring between Russia and Ukraine. We stand with the Ukrainian people and our full support lies with the people and army of Ukraine to protect their nation from this senseless act of aggression and violence. It is sickening to see citizens of Ukraine having to leave their homeland and be displaced amongst Europe to protect their safety. We have also been proud to see Ukraine’s neighbours and the rest of the EU community offering humanitarian relief and safe passages away from this vicious war. 

As a women’s health company, we have to remain strong for women caught on either side of this conflict that need and depend on our support. This will be challenging given the financial sanctions, logistical hurdles, and even our emotional struggle, but we still owe it to the women we serve to keep trying every day.  

We will continue to pray and hope for a quick ending to the war so the citizens of the Ukraine can return back safely to their country and their homes and reunite with their families. 

Robert Stewart
CEO

21 March 2022

Theramex supports the IOF SCOPE 2021 recommendations and call to action to address the inequalities in Osteoporosis care across Europe

Ler mais

10 February 2022

Theramex Announces Licensing Agreement with ObsEva for the Commercialisation of Linzagolix for the Treatment of Uterine Fibroids

Ler mais